For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...
Cancer screenings exist to try to detect the disease in its earlier stages, and ultimately to save lives. But screenings for lung cancer—the leading cause of cancer deaths worldwide—are narrow, and ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...
Dr. Daniel J. Boffa discusses advancements in lung cancer care, including the role of minimally invasive surgical techniques and new systemic therapies.
Scientists at NYU Langone discovered that blocking a key protein that shields cancer cells from a natural stress-driven death process can dramatically slow lung tumor growth.
“We are no longer treating all lung cancers the same way. With specific biomarker testing and targeted therapy, we’re seeing ...
The field of lung cancer screening has advanced significantly with the widespread implementation of low-dose computed tomography (LDCT), which has been ...
Early diagnosis of lung cancer may improve the prognosis, but many people aren’t aware they have it until it spreads. Screening tests may help detect the disease. Blood tests are not yet available to ...
Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...
Squamous cell lung cancer starts in the squamous cells: thin, flat cells that line the inside of the airways in your lungs. If you're diagnosed after the cancer has spread, it tends to be more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback